Literature DB >> 9828121

The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile.

S Yamanaka1, X Y Zhang, K Miura, S Kim, H Iwao.   

Abstract

LOX-1 is an endothelial receptor for oxidized low-density lipoprotein that plays essential roles in atherogenesis. LOX-1 has the highest homology with C-type lectin receptors expressed on natural killer cells. In the present study, we cloned and characterized the human LOX-1 gene (HGMW-approved symbol OLR1). The gene structure of LOX-1 resembles that of the natural killer cell receptors. Fluorescence in situ hybridization and analyses of a yeast artificial chromosome contig revealed that the human LOX-1 gene is located in the natural killer gene complex on chromosome 12p12-p13, where the genes of the natural killer cell receptors cluster. In contrast, the expression pattern of LOX-1 is different from that of the natural killer cell receptors; LOX-1 is expressed in vascular-rich organs, but not in lymphocytes. A 1753-bp fragment of the 5' flanking region of the LOX-1 gene had a functional promoter activity. This region contains binding sites for several transcription factors, including the STAT family and NF-IL6, and the expression of LOX-1 was upregulated by several cytokines. These results demonstrate that the human LOX-1 gene is a new member of the natural killer gene complex with a unique expression profile. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828121     DOI: 10.1006/geno.1998.5561

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.

Authors:  M Chen; S Narumiya; T Masaki; T Sawamura
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.

Authors:  Mehmet Cilingiroglu; Kerem Ozer
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

3.  Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals.

Authors:  Li Hao; Jan Klein; Masatoshi Nei
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

4.  Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification.

Authors:  Ming-Lin Liu; Rosario Scalia; Jawahar L Mehta; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-19       Impact factor: 8.311

5.  Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.

Authors:  Jiawei Chen; Yong Liu; Hongmei Liu; Paul L Hermonat; Jawahar L Mehta
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

6.  Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development.

Authors:  Yoshimi Tokuzawa; Eiko Kaiho; Masayoshi Maruyama; Kazutoshi Takahashi; Kaoru Mitsui; Mitsuyo Maeda; Hitoshi Niwa; Shinya Yamanaka
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  In vitro and in vivo analysis of expression cassettes designed for vascular gene transfer.

Authors:  S J White; E D Papadakis; C A Rogers; J L Johnson; E A L Biessen; A C Newby
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

8.  Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease.

Authors:  J-C Lambert; E Luedecking-Zimmer; S Merrot; A Hayes; U Thaker; P Desai; A Houzet; X Hermant; D Cottel; A Pritchard; T Iwatsubo; F Pasquier; B Frigard; P M Conneally; M-C Chartier-Harlin; S T DeKosky; C Lendon; D Mann; M I Kamboh; P Amouyel
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

9.  LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells.

Authors:  Jane E Murphy; Daryl Tacon; Philip R Tedbury; Jonathan M Hadden; Stuart Knowling; Tatsuya Sawamura; Michelle Peckham; Simon E V Phillips; John H Walker; Sreenivasan Ponnambalam
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

10.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.